Drug Development

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

As biologics continue to push boundaries, the industry needs to take a holistic approach to formulation to ensure success.

Rising to the Challenge of Biologic Drug Formulation

Harmonization of best practices and regulatory requirements will enable developers to find the best stability testing approach.


Key Considerations in Stability Testing

Michael Avraam is global product manager at ChargePoint Technology for the PharmaSafe range of products.

Containment valves and smart monitoring can keep employees safe and improve manufacturing efficiency when handling potent APIs, intermediates, and solid-dosage drugs.

Assuring the Safe Handling of Potent APIs, Intermediates, and Solid-Dosage Drugs

Agnes Shanley is senior editor of Pharmaceutical Technology.

While allogeneic therapies can use existing regulatory and quality frameworks, autologous treatments will require pharma’s adoption of true just-in-time and right-first-time concepts, says consultant James Blackwell.


Reinterpreting Benchmarks for Innovative Therapies

STA Pharmaceuticals and BioLingus have announced the formation of an exclusive technology and marketing collaboration for sublingual delivery.


Exclusive Agreement Forms for Sublingual Delivery

The technology uses a silica nanoparticle to deliver vaccines and cancer treatments.

N4 Pharma Develops Nanoparticle Technology for Vaccine Delivery

The Coalition for Epidemic Preparedness Innovations (CEPI) and CureVac partner to develop a transportable mRNA vaccine manufacturing platform.

CEPI, CureVac Partner to Develop mRNA Vaccine Manufacturing Platform

A project conducted by research institute CEA-Leti led to the development of a new HIV vaccine approach based on engineered lipid nanoparticles.

New Vaccine for HIV Using Lipid-Nanoparticle Technology

Valitacell and Solentim, have announced a collaboration aimed at the acceleration of discovery and development of biologic drugs and advanced cell therapies.

Valitacell, Solentim Collaborate to Accelerate Development of Breakthrough Medicines

In a statement, FDA Commissioner Scott Gottlieb laid out the case for the safety and effectiveness of generic drugs compared to brand drugs.

Formulation and Drug Delivery